The Methyltestosterone Tablets, cataloged under National Stock Number 6505-00-619-7929, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Ciba-Geigy Corp Ciba Pharmaceuticals Div. Government technical data includes 5 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 3 commercial cross-references from 1 manufacturer, enabling identification through both NSN and commercial part number lookups. 12 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Cancelled.
| Parameter | Value |
|---|---|
| NSN | 6505-00-619-7929 |
| Primary Part Number | 1432 |
| Item Name | Methyltestosterone Tablets |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Ciba-Geigy Corp Ciba Pharmaceuticals Div |
| Status | CANCELLED |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Administration | ORAL |
| Primary Container Content Quantity | 100.000 TABLETS |
| Active Medicament Medicinal Strength | 5.000 MILLIGRAMS METHYLTESTOSTERONE ACTIVE INGREDIENT |
| Acquisition Status | CANCELLED |
| HAZMAT | No |
| Part Number | Manufacturer |
|---|---|
| METANDREN LINGUET | Ciba-Geigy Corp Ciba Pharmaceuticals Div (USA) |
| 1432 PRIMARY | Ciba-Geigy Corp Ciba Pharmaceuticals Div (USA) |
| NDC00083-0051-30 PRIMARY | Ciba-Geigy Corp Ciba Pharmaceuticals Div (USA) |
NSN 6505-00-619-7929 is a Methyltestosterone Tablets, manufactured by Ciba-Geigy Corp Ciba Pharmaceuticals Div, classified under FSC 6505 (No Item Name Available). Status: cancelled.
NSN 6505-00-619-7929 has 3 cross-referenced part numbers: METANDREN LINGUET (Ciba-Geigy Corp Ciba Pharmaceuticals Div), 1432 (Ciba-Geigy Corp Ciba Pharmaceuticals Div), NDC00083-0051-30 (Ciba-Geigy Corp Ciba Pharmaceuticals Div).
There are 12 known substitutes for 6505-00-619-7929: 5120-00-203-4812, 5999-00-233-0282, 5330-00-270-8467 and 9 more. Verify interchangeability with system specifications before substitution.
Key specifications for 1432: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Administration: ORAL; Primary Container Content Quantity: 100.000 TABLETS. 5 total characteristics are documented in the Federal Logistics Information System.
NSN 6505-00-619-7929 is currently cancelled. Check with the Defense Logistics Agency for current availability and authorized substitutes.